TELA Bio (TELA) Amortization of Deferred Charges (2018 - 2026)
TELA Bio has reported Amortization of Deferred Charges over the past 8 years, most recently at $159000.0 for Q4 2025.
- For Q4 2025, Amortization of Deferred Charges rose 3.25% year-over-year to $159000.0; the TTM value through Dec 2025 reached $529000.0, down 13.14%, while the annual FY2025 figure was $529000.0, 13.14% down from the prior year.
- Amortization of Deferred Charges for Q4 2025 was $159000.0 at TELA Bio, up from $110000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $181000.0 in Q2 2022 and troughed at $109000.0 in Q2 2025.
- A 5-year average of $152900.0 and a median of $151500.0 in 2023 define the central range for Amortization of Deferred Charges.
- Biggest five-year swings in Amortization of Deferred Charges: grew 16.42% in 2021 and later dropped 28.1% in 2025.
- Year by year, Amortization of Deferred Charges stood at $176000.0 in 2021, then dropped by 14.77% to $150000.0 in 2022, then grew by 1.33% to $152000.0 in 2023, then grew by 1.32% to $154000.0 in 2024, then grew by 3.25% to $159000.0 in 2025.
- Business Quant data shows Amortization of Deferred Charges for TELA at $159000.0 in Q4 2025, $110000.0 in Q3 2025, and $109000.0 in Q2 2025.